MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 1 filers reported holding MIRATI THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72,663,133 | +39.3% | 1,668,116 | +15.5% | 4.93% | +22.3% |
| Q2 2023 | $52,163,121 | +0.4% | 1,443,762 | +3.4% | 4.03% | -18.1% |
| Q1 2023 | $51,932,243 | -9.6% | 1,396,779 | +10.2% | 4.92% | -27.0% |
| Q4 2022 | $57,451,721 | -3.3% | 1,267,970 | +49.1% | 6.74% | -14.8% |
| Q3 2022 | $59,391,000 | +34.1% | 850,385 | +28.9% | 7.92% | -10.4% |
| Q2 2022 | $44,304,000 | +447.7% | 659,968 | +570.8% | 8.83% | +313.0% |
| Q1 2022 | $8,089,000 | -78.8% | 98,383 | -62.2% | 2.14% | -80.4% |
| Q4 2021 | $38,156,000 | – | 260,115 | – | 10.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,000,000 | $31,470,000 | 8.67% |
| Baker Brothers Advisors | 2,805,074 | $88,276,000 | 0.77% |
| Broadfin Capital, LLC | 359,661 | $11,319,000 | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 397,660 | $12,514,000 | 0.42% |
| Boulegeris Investments, Inc. | 17,415 | $548,000 | 0.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 95,000 | $2,990,000 | 0.29% |
| Rhenman & Partners Asset Management AB | 50,000 | $1,574,000 | 0.19% |
| Integre Asset Management, LLC | 23,996 | $755,000 | 0.16% |
| Orbimed Advisors | 680,500 | $21,415,000 | 0.16% |
| EAM Investors, LLC | 38,754 | $1,220,000 | 0.14% |